← 返回

肿瘤内在对 IFN-γ 促凋亡效应的敏感性是 CD4⁺ CAR-T 细胞抗肿瘤活性的主要决定因素

英文原题:Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4(+) CAR T-cell antitumor activity.

查看英文原题

Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4(+) CAR T-cell antitumor activity.

PubMed 2023/05/29(内容时间) Nat Cancer Q1 · IF 28(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

CD4+ T细胞和CD4+嵌合抗原受体(CAR)T细胞在临床前模型和患者中显示出高度可变的抗肿瘤活性;然而,决定CD4+ T细胞如何以及何时促进肿瘤消退的机制尚不完全清楚。借助功能性活体成像,我们报告,干扰素(IFN)-的产生而非穿孔素介导的细胞毒性是抗CD19 CD4+ CAR-T 细胞消除肿瘤的主要机制。在机制上,小鼠或人CD4+ CAR-T 细胞衍生的IFN-广泛扩散,远距离作用于肿瘤细胞,选择性杀伤对细胞因子诱导的凋亡敏感的肿瘤,包括抗原阴性变异体。在接受抗CD19 CAR-T 细胞治疗且CAR CD4:CD8比值升高的患者中,血清IFN-的强烈诱导与生存期增加相关。我们提出,肿瘤细胞对IFN-促凋亡活性的敏感性是CD4+ CAR-T 细胞疗效的主要决定因素,并可考虑用于指导免疫治疗期间CD4+ T细胞的使用。

展开英文摘要原文

CD4 + T cells and CD4 + chimeric antigen receptor (CAR) T cells display highly variable antitumor activity in preclinical models and in patients; however, the mechanisms dictating how and when CD4 + T cells promote tumor regression are incompletely understood. With the help of functional intravital imaging, we report that interferon (IFN)- production but not perforin-mediated cytotoxicity was the dominant mechanism for tumor elimination by anti-CD19 CD4 + CAR T cells.

Mechanistically, mouse or human CD4 + CAR T-cell-derived IFN- diffused extensively to act on tumor cells at distance selectively killing tumors sensitive to cytokine-induced apoptosis, including antigen-negative variants. In anti-CD19 CAR T-cell-treated patients exhibiting elevated CAR CD4:CD8 ratios, strong induction of serum IFN- was associated with increased survival.

We propose that the sensitivity of tumor cells to the pro-apoptotic activity of IFN- is a major determinant of CD4 + CAR T-cell efficacy and may be considered to guide the use of CD4 + T cells during immunotherapy.

论文信息

作者
Boulch M、Cazaux M、Cuffel A、Guerin MV、Garcia Z、Alonso R、Lemaître F、Beer A
第一作者单位
Institut Pasteur, Université de Paris Cité, INSERM U1223, Dynamics of Immune Responses Unit, Equipe Labellisée Ligue Contre le Cancer, Paris, France.France
通讯作者单位
Institut Pasteur, Université de Paris Cité, INSERM U1223, Dynamics of Immune Responses Unit, Equipe Labellisée Ligue Contre le Cancer, Paris, France. philippe.bousso@pasteur.fr.France
文献类型
非美国政府资助研究
期刊
Nature cancer2023 Jul
原文标识
PubMed 37248395 · DOI 10.1038/s43018-023-00570-7